This webinar will describe the intrinsic potential of droplet digital (ddPCR) in clinical research for three different applications.
TORONTO (PRWEB) November 19, 2020
Since becoming commercially available in 2011, digital PCR (dPCR) has been gaining in popularity as it enables nucleic acid quantification with superior accuracy and precision compared to quantitative PCR (qPCR).
With data acquisition taking place at the end of the reaction, and since absolute concentrations can be determined, data can be easily interpreted and compared across different samples and experiments, especially in a clinical setting. Additionally, dPCR doesn’t suffer from the inherent complications of qPCR that result from the requirement of a standard curve, and excels in the quantification of low abundant genes or small differences.
This webinar will describe the intrinsic potential of droplet digital (ddPCR) in clinical research for three different applications:
- Rare variant analysis in plasma samples
- Small changes in alternative splicing
- CAR-T studies
During the talk, the featured speaker will analyze the rationale for dPCR selection and present relevant case studies.
For more information, or to register for this event, visit Applications of Digital PCR in Clinical Research.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.